|

Polkadot price presents cautious outlook as DOT bears target $13 next

  • Polkadot price could be headed lower as the governing technical pattern presents a cause for concern.
  • DOT may be able to search for reliable support at $16.95 before dropping toward the downside trend line of the governing technical pattern.
  • If selling pressure continues to increase, Polkadot could fall toward the pessimistic target at $13.17.

Polkadot price has formed a cautious outlook as the token continued to record lower highs and lower lows. DOT has presented a bearish target at $13.17, with validation if it fails to slice above the upper boundary of the governing technical pattern at $21.77.

Polkadot price locked in downtrend

Polkadot price has formed a descending parallel channel on the daily chart, raising concern for DOT buyers. The token has projected a 30% fall toward $13.17 if the key levels of support fail to hold.

The first line of defense for Polkadot price is at the 78.6% Fibonacci retracement level at $17.91. Additional selling pressure may see DOT test the support line given by the Momentum Reversal Indicator (MRI) at $16.95, coinciding with the middle boundary of the governing technical pattern.

Polkadot price may then test the January 24 low at $15.80 next if bearish sentiment continues to increase. Falling below this level could put the pessimistic target at $13.17 on the radar, where the lower boundary of the prevailing chart pattern is located, coinciding with the 127.2% Fibonacci extension level.

Investors should note that if the aforementioned pessimistic target is a level not seen since July 27.

DOT

DOT/USDT daily chart

However, if buying pressure increases, Polkadot price may aim to tag the 21-day Simple Moving Average (SMA) at $19.49, intersecting with the 61.8% Fibonacci retracement level. 

An additional spike in buy orders may push DOT price higher toward the 38.2% Fibonacci retracement level at $21.77, coinciding with the upper boundary of the prevailing chart pattern.

If Polkadot price manages to break above the topside trend line of the governing technical pattern, the bearish outlook may be voided. 

Author

Sarah Tran

Sarah Tran

Independent Analyst

Sarah has closely followed the growth of blockchain technology and its adoption since 2016.

More from Sarah Tran
Share:

Editor's Picks

Cosmos Hub Price Forecast: ATOM rebounds slightly, bearish outlook remains intact

Cosmos Hub (ATOM) price rebounds, trading above $2.05 at the time of writing on Wednesday, after undergoing a sharp correction since last week. Weakening on-chain and derivatives data support a bearish outlook, while technical analysis remains unfavorable.

BTC, ETH and XRP post cautious recovery amid downside risks

Bitcoin, Ethereum, and Ripple are posting a cautious recovery on Wednesday following a market correction earlier this week.  BTC is approaching a key breakdown level, while ETH and XRP are rebounding from crucial support levels. 

Top Crypto Gainers:  Morpho, Ether.fi, and Pippin rally amid market pressure

Altcoins, including Morpho, Ether.fi and Pippin are leading the gains over the last 24 hours as the broader cryptocurrency market remains under pressure. Technically, the recovery in MORPHO, ETHFI, and PIPPIN shows upside potential as buying pressure increases.

Hyperliquid registers mild gains following CoinShares' ETP launch

Hyperliquid (HYPE) registered a 3% gain on Tuesday after CoinShares announced the launch of its Physical Hyperliquid Staking exchange-traded product (ETP), offering investors exposure to the token's price and staking yields.

Bitcoin Price Annual Forecast: BTC holds long-term bullish structure heading into 2026

Bitcoin (BTC) is wrapping up 2025 as one of its most eventful years, defined by unprecedented institutional participation, major regulatory developments, and extreme price volatility.

Bitcoin: No recovery in sight

Bitcoin (BTC) price continues to trade within a range-bound zone, hovering around $67,000 at the time of writing on Friday, and falling slightly so far this week, with no signs of recovery.